Hydrocortisone Sodium Succinate for Injection Succinate D'hydrocortisone Pour Injection Hydrocortisone

China Hydrocortisone Sodium Succinate for Injection Succinate D′hydrocortisone Pour Injection Hydrocortisone, Find details about China Hydrocortisone Sodium Succinate for Injection, Powder Injection from Hydrocortisone Sodium Succinate for Injection Succinate D′hydrocortisone Pour Injection Hydrocortisone

Model NO.
100mg
Pharmaceutical Technology
Chemical Synthesis
Export
for Export Use Only
Trademark
TAOLIGHT PHARMA
Specification
100MG
Origin
China
HS Code
3004909099
Model NO.
100mg
Pharmaceutical Technology
Chemical Synthesis
Export
for Export Use Only
Trademark
TAOLIGHT PHARMA
Specification
100MG
Origin
China
HS Code
3004909099
[Pharmaceutical properties]
This product is a white or almost white loose mass.
[Adverse reactions]
Glucocorticoids have no obvious adverse reactions when using physiological dose replacement therapy. Adverse reactions occur mostly when pharmacological doses are applied, and are closely related to the course of treatment, dosage, type of drug, usage and route of administration.
[product specifications]
50mg (according to hydrocortisone)
Pharmaceutical Ingredients
The main component of this product is: hydrocortisone sodium succinate
[Pregnant women medication]
(1) medication during pregnancy: glucocorticoids can pass through the placenta. Animal studies have shown that administration during pregnancy can increase the incidence of embryonic cleft palate, placental insufficiency, spontaneous abortion and intrauterine growth retardation. Human use of pharmacological doses of glucocorticoids can increase placental dysfunction, neonatal weight loss, or the incidence of stillbirth.
(2) lactation medication: glucocorticoids can be excreted in the milk, causing adverse effects on the baby, such as growth inhibition, inhibition of adrenal function. Pregnant women and lactating women should avoid using them as much as possible when weighing the pros and cons.
[Children's medication]
Children with long-term use of adrenocortical hormones must be very careful.
[medication in elderly patients]
Elderly patients with glucocorticoids are prone to high blood pressure and diabetes. Older patients, especially women after menopause, are prone to aggravate osteoporosis with glucocorticoids.
[Usage and Dosage]
Before use, dilute with physiological sodium chloride injection or 5% glucose injection. Intravenous injection for the treatment of adult adrenal insufficiency and anterior pituitary dysfunction crisis, severe allergic reaction, asthma persistent state, shock, intravenous infusion of 100 mg of each free form or hydrocortisone sodium succinate, available to each The daily dose is 300mg to 400mg, and the course of treatment is no more than 3-5 days.
[Storage method] Sealed and stored in shading.
Precautions
1. Induced infection: Under the action of hormones, the infection that has been controlled can be active. The most common one is the recurrence of tuberculosis infection. In some infections, the application of hormones can reduce the destruction of tissues, reduce exudation, and alleviate the symptoms of infection. However, it is necessary to treat with effective antibiotics at the same time, and closely observe the changes in the condition. After short-term medication, it should be quickly reduced and stopped.
2. Interference with the diagnosis:
(1) Glucocorticoids can increase blood sugar, blood cholesterol, blood fatty acids, blood sodium levels, and reduce blood calcium and blood potassium.
(2) The influence of peripheral blood on lymphocytes, eukaryotic cells and eosinophils, basophils decreased, polynuclear white blood cells and platelets increased, the latter may also decline.

for Export use only